BGM (BGM Group) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGM BGM Group Ltd BGM
35 GF Score
Price $0.28
GF Value $0.26
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is BGM Group Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

BGM
35GF Score
BGM Group Ltd BGM
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be overvalued. The current stock price of $0.28 is trading 8.1% above its estimated GF Value™ of $0.26. GuruFocus considers BGM Group to be Fairly Valued.

Key valuation signals for BGM:

  • Short Ratio:
  • GF Value™: $0.26 vs. price of $0.28 (8.1% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BGM Group Business Description

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
35GF Score

Get the complete analysis for BGM

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.28
Price
$0.26
GF Value